Motif ID: Ppara
Z-value: 1.825
Transcription factors associated with Ppara:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Ppara | ENSMUSG00000022383.7 | Ppara |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.4 | 19.3 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
5.2 | 15.5 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
5.0 | 14.9 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
4.4 | 17.6 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
4.3 | 13.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
4.2 | 12.7 | GO:1904347 | intestine smooth muscle contraction(GO:0014827) regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) regulation of small intestine smooth muscle contraction(GO:1904347) small intestine smooth muscle contraction(GO:1990770) |
3.5 | 31.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
3.4 | 17.2 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
3.3 | 10.0 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
3.3 | 13.0 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
3.1 | 12.5 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
3.1 | 15.5 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
2.8 | 8.3 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
2.5 | 9.8 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
2.4 | 12.1 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
2.3 | 6.8 | GO:0019046 | release from viral latency(GO:0019046) regulation of DNA strand elongation(GO:0060382) |
2.2 | 19.9 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
2.2 | 6.6 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
2.1 | 21.2 | GO:0061470 | interleukin-21 production(GO:0032625) T follicular helper cell differentiation(GO:0061470) interleukin-21 secretion(GO:0072619) |
2.0 | 8.0 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
2.0 | 5.9 | GO:2000331 | regulation of terminal button organization(GO:2000331) |
1.9 | 24.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
1.7 | 12.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
1.6 | 6.5 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
1.6 | 4.8 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.6 | 23.9 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
1.5 | 7.5 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
1.5 | 4.4 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
1.4 | 7.1 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
1.4 | 4.3 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
1.3 | 8.9 | GO:0030242 | pexophagy(GO:0030242) |
1.3 | 11.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
1.2 | 3.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.2 | 3.7 | GO:0032430 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
1.2 | 7.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
1.2 | 2.4 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
1.2 | 3.6 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
1.1 | 6.9 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
1.1 | 4.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.1 | 22.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.1 | 5.6 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.1 | 21.2 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
1.1 | 6.6 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.1 | 15.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
1.0 | 4.2 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
1.0 | 3.1 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
1.0 | 3.1 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
1.0 | 28.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
1.0 | 4.0 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.9 | 3.7 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.9 | 8.4 | GO:0009644 | response to high light intensity(GO:0009644) |
0.9 | 4.6 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.9 | 2.8 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.9 | 3.7 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
0.9 | 4.6 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.9 | 7.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.9 | 3.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.9 | 10.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.9 | 16.3 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.9 | 9.4 | GO:0060539 | diaphragm development(GO:0060539) |
0.8 | 5.8 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.8 | 4.1 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.8 | 6.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.8 | 4.8 | GO:1903056 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
0.8 | 3.2 | GO:0006848 | pyruvate transport(GO:0006848) |
0.8 | 11.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.8 | 2.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) negative regulation of protein import into nucleus, translocation(GO:0033159) oligodendrocyte apoptotic process(GO:0097252) regulation of oligodendrocyte apoptotic process(GO:1900141) negative regulation of oligodendrocyte apoptotic process(GO:1900142) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.8 | 2.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.8 | 4.5 | GO:0015879 | carnitine transport(GO:0015879) |
0.8 | 2.3 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.8 | 2.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.7 | 2.2 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.7 | 5.2 | GO:0090234 | cellular response to testosterone stimulus(GO:0071394) regulation of kinetochore assembly(GO:0090234) |
0.7 | 2.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) aspartate catabolic process(GO:0006533) alditol biosynthetic process(GO:0019401) |
0.7 | 2.1 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.7 | 7.8 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.7 | 19.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.7 | 4.2 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.7 | 2.1 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.7 | 2.0 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.7 | 2.7 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.7 | 8.7 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.7 | 2.7 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.7 | 1.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.7 | 3.3 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.7 | 0.7 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) |
0.7 | 11.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.7 | 1.3 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.6 | 1.9 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.6 | 26.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.6 | 5.6 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.6 | 5.0 | GO:0097264 | self proteolysis(GO:0097264) |
0.6 | 2.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.6 | 6.7 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.6 | 1.8 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.6 | 3.0 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.6 | 1.8 | GO:0060003 | copper ion export(GO:0060003) cellular response to manganese ion(GO:0071287) |
0.6 | 2.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.6 | 3.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.6 | 1.7 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) |
0.5 | 7.6 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.5 | 13.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 2.1 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.5 | 1.6 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.5 | 2.6 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.5 | 3.6 | GO:0035826 | hypotonic response(GO:0006971) rubidium ion transport(GO:0035826) cellular hypotonic response(GO:0071476) |
0.5 | 2.0 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.5 | 5.1 | GO:0046512 | sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
0.5 | 2.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.5 | 2.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.5 | 9.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.5 | 2.4 | GO:0015692 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
0.5 | 2.9 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) phosphate ion transmembrane transport(GO:0035435) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.5 | 1.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.5 | 2.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.5 | 1.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.5 | 1.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.5 | 7.5 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.5 | 1.8 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.5 | 3.7 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.4 | 2.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 8.8 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.4 | 1.3 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.4 | 2.6 | GO:0046103 | ADP biosynthetic process(GO:0006172) inosine biosynthetic process(GO:0046103) |
0.4 | 2.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.4 | 3.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.4 | 0.8 | GO:0070142 | synaptic vesicle budding(GO:0070142) |
0.4 | 1.3 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.4 | 2.5 | GO:0051665 | membrane raft localization(GO:0051665) |
0.4 | 2.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.4 | 4.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.4 | 1.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.4 | 9.7 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.4 | 3.9 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.4 | 3.0 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.4 | 5.7 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.4 | 3.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.4 | 1.1 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.4 | 3.2 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.4 | 3.2 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.4 | 3.9 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.4 | 1.4 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.4 | 2.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.4 | 4.9 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.3 | 1.0 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 2.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 2.8 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
0.3 | 2.4 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.3 | 1.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.3 | 16.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.3 | 13.0 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.3 | 1.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.3 | 3.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.3 | 2.9 | GO:0099628 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
0.3 | 1.6 | GO:0018377 | N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
0.3 | 2.2 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.3 | 4.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.3 | 2.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 1.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 1.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.3 | 5.8 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.3 | 0.8 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
0.3 | 0.8 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.3 | 9.8 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.3 | 1.8 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.3 | 4.2 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.3 | 1.0 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.3 | 0.3 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
0.3 | 1.0 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.3 | 1.3 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
0.3 | 12.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.3 | 4.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 4.7 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.2 | 6.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 2.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 1.0 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.2 | 1.0 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 5.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 1.0 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.2 | 0.5 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.2 | 6.2 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.2 | 1.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 11.5 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.2 | 1.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 0.9 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.2 | 2.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 4.5 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.2 | 0.9 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.2 | 1.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 2.4 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.2 | 1.1 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.2 | 0.7 | GO:2000612 | pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) kidney rudiment formation(GO:0072003) kidney field specification(GO:0072004) regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) negative regulation of somatic stem cell population maintenance(GO:1904673) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of thyroid hormone generation(GO:2000609) positive regulation of thyroid hormone generation(GO:2000611) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.2 | 3.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 36.8 | GO:0051017 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
0.2 | 11.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 0.6 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.2 | 5.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 9.5 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.2 | 1.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) lipid glycosylation(GO:0030259) |
0.2 | 1.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 5.6 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.2 | 1.4 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.2 | 3.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 1.0 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 1.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 0.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.2 | 1.5 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 2.7 | GO:0016358 | dendrite development(GO:0016358) |
0.2 | 0.8 | GO:2000189 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 1.3 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.2 | 3.4 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.2 | 0.6 | GO:0016056 | photoreceptor cell morphogenesis(GO:0008594) rhodopsin mediated signaling pathway(GO:0016056) post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.2 | 7.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 2.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 3.0 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.2 | 1.0 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 1.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 3.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.2 | 0.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.3 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.2 | 16.1 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.2 | 0.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) |
0.2 | 0.6 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.2 | 2.1 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.1 | 1.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 1.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 1.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 1.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.7 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.5 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.1 | 0.5 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.1 | 1.1 | GO:1902255 | fat pad development(GO:0060613) positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.7 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.9 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.1 | 1.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 1.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 1.7 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.1 | 1.6 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 1.4 | GO:0015809 | arginine transport(GO:0015809) |
0.1 | 2.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 1.1 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 2.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 1.3 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.1 | 4.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 4.1 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 1.2 | GO:0097484 | dendrite extension(GO:0097484) |
0.1 | 3.4 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 5.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 32.1 | GO:0051260 | protein homooligomerization(GO:0051260) |
0.1 | 0.7 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 2.8 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 1.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 1.4 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 2.6 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 0.3 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.1 | 1.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 2.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 2.0 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 5.0 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 7.6 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.1 | 1.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.9 | GO:0051231 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 2.0 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 1.0 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.8 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.1 | 1.1 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 1.5 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.1 | 0.6 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 4.6 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 1.9 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 3.8 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 2.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.2 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.1 | 0.3 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.8 | GO:0048536 | spleen development(GO:0048536) |
0.1 | 0.1 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.1 | 0.3 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.1 | 3.1 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.1 | 1.3 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 1.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 4.1 | GO:0021549 | cerebellum development(GO:0021549) |
0.1 | 5.2 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.1 | 1.0 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.6 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 5.4 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.1 | 0.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 1.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0071677 | positive regulation of T cell chemotaxis(GO:0010820) positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 0.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 8.9 | GO:0043413 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.0 | 1.5 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.2 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 1.0 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
0.0 | 0.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 1.0 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.0 | 0.3 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.6 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.4 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 3.1 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 1.6 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.3 | GO:0050773 | regulation of dendrite development(GO:0050773) |
0.0 | 0.2 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.0 | 0.4 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.0 | 1.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 5.8 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 1.6 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.3 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.6 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.0 | 0.4 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 1.2 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
0.0 | 1.3 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.9 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.0 | 0.3 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 0.8 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 3.4 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.0 | 0.3 | GO:0045471 | response to ethanol(GO:0045471) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 13.0 | GO:0072534 | perineuronal net(GO:0072534) |
3.5 | 17.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
3.4 | 50.7 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
3.3 | 13.0 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
1.9 | 7.4 | GO:0032280 | symmetric synapse(GO:0032280) |
1.7 | 15.0 | GO:0097427 | microtubule bundle(GO:0097427) |
1.6 | 17.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.6 | 4.7 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.3 | 6.6 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
1.3 | 13.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.2 | 6.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
1.2 | 10.9 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.2 | 7.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.0 | 3.1 | GO:0018444 | translation release factor complex(GO:0018444) |
1.0 | 8.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.9 | 1.8 | GO:0016939 | kinesin II complex(GO:0016939) |
0.9 | 1.8 | GO:0097444 | spine apparatus(GO:0097444) |
0.9 | 15.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.9 | 8.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.9 | 16.5 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.7 | 2.8 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.7 | 13.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.6 | 5.8 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.6 | 3.1 | GO:1902710 | G-protein coupled receptor heterodimeric complex(GO:0038039) GABA receptor complex(GO:1902710) |
0.6 | 4.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.6 | 3.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.6 | 15.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.5 | 10.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.5 | 2.6 | GO:0032437 | cuticular plate(GO:0032437) |
0.5 | 2.0 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.5 | 2.5 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.5 | 2.4 | GO:0070826 | paraferritin complex(GO:0070826) |
0.5 | 1.4 | GO:0030496 | midbody(GO:0030496) |
0.5 | 3.8 | GO:0031415 | NatA complex(GO:0031415) |
0.5 | 10.5 | GO:0031430 | M band(GO:0031430) |
0.5 | 1.9 | GO:0005745 | m-AAA complex(GO:0005745) |
0.5 | 1.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
0.4 | 4.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.4 | 2.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 1.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 5.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.4 | 5.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 2.2 | GO:0043679 | axon terminus(GO:0043679) |
0.4 | 1.1 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.4 | 2.1 | GO:0005874 | microtubule(GO:0005874) |
0.3 | 0.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 2.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 1.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 7.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.3 | 4.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 7.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 4.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 2.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 2.8 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) U2AF(GO:0089701) |
0.3 | 0.3 | GO:0030427 | site of polarized growth(GO:0030427) |
0.3 | 2.4 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 0.6 | GO:1990761 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.3 | 2.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 1.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 1.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 9.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 4.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 13.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 3.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.3 | 2.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 35.0 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 2.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 8.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 5.5 | GO:0099738 | cell cortex region(GO:0099738) |
0.2 | 1.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 3.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 30.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 1.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 0.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.2 | 2.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 27.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 45.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 2.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 8.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 15.6 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 9.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 7.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 2.3 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 9.5 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 1.5 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 1.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 7.9 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 4.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 11.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 16.4 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 2.4 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 3.4 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 8.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 2.4 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 2.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 6.0 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 4.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 1.4 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.8 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 10.7 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 1.0 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.1 | 1.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 2.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 1.0 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 3.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 1.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 1.0 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 1.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.7 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 1.9 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 1.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 4.4 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.3 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 2.9 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.5 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 1.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 9.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 9.2 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 1.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 1.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 6.1 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.1 | 5.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 7.4 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 4.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 37.6 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 27.3 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 3.5 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 2.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 4.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 3.0 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 1.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 1.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 1.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.8 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.3 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 2.5 | GO:0044297 | cell body(GO:0044297) |
0.1 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.3 | GO:0005719 | euchromatin(GO:0000791) nuclear euchromatin(GO:0005719) |
0.0 | 1.3 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 1.7 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 1.5 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 2.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.0 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 0.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.6 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 3.7 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 3.2 | GO:0005814 | centriole(GO:0005814) |
0.0 | 5.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 2.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 3.4 | GO:0071944 | cell periphery(GO:0071944) |
0.0 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 3.3 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 3.3 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 0.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 1.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.5 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 4.1 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.5 | GO:0005811 | lipid particle(GO:0005811) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 20.9 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
4.3 | 13.0 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
4.2 | 12.7 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
4.2 | 12.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
3.6 | 25.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
3.2 | 19.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
3.1 | 15.5 | GO:0055100 | adiponectin binding(GO:0055100) |
3.1 | 9.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
2.8 | 11.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
2.8 | 8.3 | GO:0031403 | lithium ion binding(GO:0031403) |
2.7 | 16.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
2.6 | 10.2 | GO:0001847 | opsonin receptor activity(GO:0001847) |
2.2 | 13.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
2.1 | 35.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
2.0 | 8.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.0 | 11.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.8 | 12.7 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.6 | 6.5 | GO:0070976 | calcium-independent protein kinase C activity(GO:0004699) TIR domain binding(GO:0070976) |
1.5 | 4.5 | GO:0005124 | scavenger receptor binding(GO:0005124) |
1.5 | 7.5 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
1.4 | 7.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.4 | 15.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
1.4 | 12.5 | GO:0030274 | LIM domain binding(GO:0030274) |
1.3 | 9.4 | GO:0015197 | peptide transporter activity(GO:0015197) |
1.3 | 3.9 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
1.3 | 3.9 | GO:0035500 | MH2 domain binding(GO:0035500) |
1.3 | 7.8 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
1.3 | 3.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.2 | 3.7 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) oncostatin-M receptor activity(GO:0004924) |
1.1 | 14.9 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.1 | 4.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.1 | 3.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.1 | 6.6 | GO:0002135 | CTP binding(GO:0002135) |
1.1 | 3.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
1.1 | 12.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.0 | 4.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.0 | 2.9 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
1.0 | 15.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.9 | 3.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.9 | 3.5 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.8 | 32.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.8 | 11.5 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.7 | 3.0 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.7 | 2.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.7 | 2.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.7 | 2.8 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.7 | 4.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.7 | 4.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.6 | 2.5 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.6 | 4.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) heterotrimeric G-protein binding(GO:0032795) |
0.6 | 1.9 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.6 | 8.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.6 | 1.8 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.6 | 5.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.6 | 2.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.6 | 7.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.6 | 2.2 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.6 | 2.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.6 | 29.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.5 | 2.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.5 | 3.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.5 | 21.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.5 | 3.1 | GO:0016917 | G-protein coupled GABA receptor activity(GO:0004965) GABA receptor activity(GO:0016917) |
0.5 | 15.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.5 | 2.4 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.5 | 2.4 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.5 | 10.8 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.5 | 1.4 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.5 | 10.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.5 | 2.8 | GO:0017040 | ceramidase activity(GO:0017040) |
0.5 | 1.8 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.4 | 2.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.4 | 19.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.4 | 1.3 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.4 | 1.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 2.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.4 | 7.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.4 | 7.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 3.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.4 | 13.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 3.0 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.4 | 6.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.4 | 5.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.4 | 1.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.4 | 5.1 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 1.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 3.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.4 | 6.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 1.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 1.4 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.3 | 2.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 3.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 6.5 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.3 | 1.9 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.3 | 5.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.3 | 2.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 1.2 | GO:0050436 | microfibril binding(GO:0050436) |
0.3 | 6.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.3 | 8.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 27.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.3 | 4.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 14.9 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.3 | 3.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 1.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.3 | 1.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 1.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 1.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.3 | 3.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.3 | 9.1 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 4.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 6.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 8.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 2.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 1.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 2.8 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 1.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 4.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 7.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 5.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.9 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.2 | 1.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 9.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 3.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 3.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 2.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 7.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.2 | 1.4 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 0.8 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 5.5 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 2.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 2.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 2.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 1.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 6.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 0.5 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
0.2 | 3.6 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.2 | 1.4 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.2 | 5.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.8 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 1.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 1.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 1.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 8.1 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.2 | 1.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 9.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 1.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 4.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 4.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.8 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 6.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 2.4 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 7.0 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 15.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.8 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 2.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 3.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 5.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 2.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.8 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.1 | 2.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 46.5 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 27.3 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 2.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.3 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.1 | 9.2 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.1 | 0.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 6.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 2.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 1.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 1.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 2.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 11.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 1.2 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 7.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.9 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 1.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 5.2 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 2.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 1.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 2.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 3.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 1.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 2.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 12.8 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 2.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.9 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 2.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 1.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.3 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 1.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 1.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 8.7 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 1.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 1.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 1.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 2.7 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 10.1 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 2.1 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.4 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 3.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 1.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 3.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 1.5 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.9 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 1.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 5.7 | GO:0005543 | phospholipid binding(GO:0005543) |
0.0 | 1.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 5.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 4.3 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.8 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 2.4 | GO:0008233 | peptidase activity(GO:0008233) |
0.0 | 0.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.2 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 1.1 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 11.9 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
0.7 | 9.8 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 6.6 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
0.4 | 18.6 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.4 | 5.7 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 6.3 | ST_WNT_CA2_CYCLIC_GMP_PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 9.2 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
0.2 | 4.6 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
0.2 | 12.5 | PID_FGF_PATHWAY | FGF signaling pathway |
0.2 | 2.1 | PID_S1P_S1P1_PATHWAY | S1P1 pathway |
0.2 | 3.5 | PID_TCR_RAS_PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 5.7 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
0.2 | 29.7 | PID_PDGFRB_PATHWAY | PDGFR-beta signaling pathway |
0.2 | 5.5 | PID_PI3KCI_PATHWAY | Class I PI3K signaling events |
0.2 | 4.0 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
0.2 | 2.2 | PID_ALK2_PATHWAY | ALK2 signaling events |
0.2 | 5.6 | PID_ERBB4_PATHWAY | ErbB4 signaling events |
0.2 | 5.6 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 1.3 | PID_NECTIN_PATHWAY | Nectin adhesion pathway |
0.2 | 12.7 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 2.5 | PID_PTP1B_PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.4 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
0.1 | 1.8 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
0.1 | 8.8 | PID_NOTCH_PATHWAY | Notch signaling pathway |
0.1 | 6.0 | PID_MTOR_4PATHWAY | mTOR signaling pathway |
0.1 | 2.2 | PID_ECADHERIN_NASCENT_AJ_PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 4.3 | PID_ARF6_TRAFFICKING_PATHWAY | Arf6 trafficking events |
0.1 | 2.8 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
0.1 | 1.0 | PID_TCPTP_PATHWAY | Signaling events mediated by TCPTP |
0.1 | 4.8 | PID_TGFBR_PATHWAY | TGF-beta receptor signaling |
0.1 | 2.3 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.8 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 2.5 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.0 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 5.9 | PID_P53_DOWNSTREAM_PATHWAY | Direct p53 effectors |
0.1 | 3.0 | PID_MYC_REPRESS_PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.5 | PID_PS1_PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.4 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
0.0 | 1.3 | PID_LKB1_PATHWAY | LKB1 signaling events |
0.0 | 0.4 | PID_CONE_PATHWAY | Visual signal transduction: Cones |
0.0 | 0.9 | PID_ATF2_PATHWAY | ATF-2 transcription factor network |
0.0 | 0.4 | PID_IL6_7_PATHWAY | IL6-mediated signaling events |
0.0 | 2.0 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 25.5 | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | Genes involved in Transport of organic anions |
3.2 | 50.7 | REACTOME_GABA_A_RECEPTOR_ACTIVATION | Genes involved in GABA A receptor activation |
2.4 | 19.2 | REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
1.4 | 11.4 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.4 | 14.9 | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
1.2 | 38.3 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
1.0 | 11.9 | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.8 | 22.1 | REACTOME_CA_DEPENDENT_EVENTS | Genes involved in Ca-dependent events |
0.8 | 10.6 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.7 | 2.1 | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.6 | 22.4 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
0.6 | 5.7 | REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.6 | 24.1 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 21.6 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.5 | 11.4 | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | Genes involved in DCC mediated attractive signaling |
0.5 | 5.8 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 5.7 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 8.5 | REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.4 | 2.9 | REACTOME_ENDOGENOUS_STEROLS | Genes involved in Endogenous sterols |
0.4 | 5.8 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 4.1 | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.4 | 11.4 | REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.4 | 8.8 | REACTOME_INSULIN_RECEPTOR_RECYCLING | Genes involved in Insulin receptor recycling |
0.4 | 5.6 | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.4 | 8.4 | REACTOME_HS_GAG_DEGRADATION | Genes involved in HS-GAG degradation |
0.4 | 4.7 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 4.4 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 2.5 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
0.3 | 2.9 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 4.3 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 2.8 | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 4.6 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 3.5 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 9.6 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 4.7 | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 9.3 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 5.1 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 6.6 | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 1.4 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 1.3 | REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.2 | 7.6 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 3.3 | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 4.5 | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 8.8 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 2.7 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 5.3 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.8 | REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 10.5 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 2.1 | REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 2.2 | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 4.1 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 2.0 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 5.1 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 3.1 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.8 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 4.5 | REACTOME_INTERFERON_GAMMA_SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 1.2 | REACTOME_SHC_RELATED_EVENTS | Genes involved in SHC-related events |
0.1 | 2.6 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.3 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 6.4 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 2.0 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 3.3 | REACTOME_GABA_RECEPTOR_ACTIVATION | Genes involved in GABA receptor activation |
0.1 | 1.6 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 2.0 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.8 | REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 0.9 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
0.1 | 2.1 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.1 | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 1.6 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.8 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.5 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.9 | REACTOME_PURINE_SALVAGE | Genes involved in Purine salvage |
0.1 | 1.0 | REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 14.3 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 3.4 | REACTOME_SIGNALING_BY_ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 1.1 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.7 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.3 | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 4.5 | REACTOME_L1CAM_INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 3.5 | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 2.4 | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 2.0 | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.9 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.6 | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.3 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.6 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 2.6 | REACTOME_SIGNALING_BY_NOTCH | Genes involved in Signaling by NOTCH |
0.0 | 0.5 | REACTOME_CIRCADIAN_CLOCK | Genes involved in Circadian Clock |
0.0 | 0.5 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 1.3 | REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.3 | REACTOME_SIGNALING_BY_EGFR_IN_CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.9 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.8 | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.5 | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 1.0 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |